Age yr Median (Interquartile range) |
74 (66–80) |
76 (69–81) |
71
(64–80) |
<.0001 |
Female sex no. (%) |
2552 (33) |
1320 (32.6) |
1232 (32.7) |
0.923 |
Body Weight kg, mean |
62.3 |
62.9 |
61.6 |
<.0001 |
BMI, mean (SD) |
24.4 (4.11) |
24.7 (4.04) |
24.0 (4.16) |
<.0001 |
Systolic Blood pressure – mmHg Mean |
126 |
127 |
126 |
0.0004 |
Paroxysmal atrial fibrillation no. (%) |
2643 (38.7) |
1304 (36.9) |
1339 (40.6) |
0.0016 |
CHADS2 score Mean |
2.44 |
2.96 |
1.89 |
<.0001 |
CHADS2 Score 0-1-no. (%) |
2063 (26.3) |
0 (0) |
1569
(41.6) |
<.0001 |
CHADS2 Score 2-no. (%) |
2252 (28.8) |
1711 (42.2) |
541 (14.3) |
<.0001 |
CHADS2 Score ≥ 3-no. (%) |
3511 (44.9) |
2343 (57.8) |
1201 (31.8) |
<.0001 |
HASBLED Score |
1.73 |
1.73 |
1.73 |
0.976 |
Prior stroke or transient ischemic attack no. (%) |
1903 (24.3) |
1270
(31.4) |
633 (16.8) |
<.0001 |
Age ≥ 75yr – no. (%) |
3755 (48.0) |
2324 (57.3) |
1431 (37.9) |
<.0001 |
Heart failure – no. (%) |
3291 (42.4) |
2020 (50.1) |
1271 (34.1) |
<.0001 |
Diabetes mellitus– no. (%) |
2444 (31.2) |
1642 (40.5) |
802 (21.3) |
<.0001 |
Hypertension– no. (%) |
6119 (78.2) |
3552 (87.7) |
2567 (68.1) |
<.0001 |
CAD–no. (%) |
2075 (27) |
1111 (27.5) |
964 (25.7) |
0.066 |
ACS–no. (%) |
819 (10.6) |
422 (10.6) |
397 (10.7) |
0.813 |
PCI–no. (%) |
684 (8.9) |
286 (7.2) |
398 (10.7) |
<.0001 |
CABG–no. (%) |
246 (3.2) |
125 (3.1) |
121 (3.2) |
0.767 |
COPD–no. (%) |
330 (4.2) |
177 (4.4) |
153 (4.1) |
0.496 |
Chronic liver disease–no. (%) |
606 (7.8) |
290 (7.2) |
316 (8.4) |
0.0425 |
History of cancer–no. (%) |
875 (11.2) |
453 (11.2) |
422 (11.2) |
0.972 |
History of RFCA–no. (%) |
623 (8.0) |
261 (6.5) |
362 (9.7) |
<.0001 |
CCr mean (SD) |
63.03 (28.75) |
63.68 (24.7) |
62.34 (32.37) |
0.0486 |
PT-INR mean (SD) |
1.90 (0.38) |
1.91 (0.38) |
1.89 (0.39) |
0.0110 |
TTR mean (SD) |
73.35 (33.8) |
74.69 (33.34) |
71.91 (34.22) |
0.0003 |
ASA–no. (%) |
168 4(22) |
805 (19.93) |
879 (23.36) |
0.0002 |